We could not find any results for:
Make sure your spelling is correct or try broadening your search.
| Ticker | Name | Price | Change | Change % | Volume |
|---|---|---|---|---|---|
AIXI | XIAO I Corporation | 0.2361 | 0.1054 | 80.64% | 95,605,498 |
PFSA | Profusa Inc | 1.30 | 0.542 | 71.50% | 22,999,306 |
HUIZ | Huize Holding Ltd | 2.21 | 0.78 | 54.55% | 3,664,077 |
ZSPC | zSpace Inc | 0.143 | 0.041 | 40.20% | 65,115,975 |
SLNO | Soleno Therapeutics Inc | 51.31 | 11.82 | 29.93% | 82,719 |
FCUV | Focus Universal Inc | 3.9145 | 0.5745 | 17.20% | 25 |
VVOS | Vivos Therapeutics Inc | 1.54 | 0.22 | 16.67% | 1,038,051 |
GLOO | Gloo Holdings Inc | 6.20 | 0.85 | 15.89% | 11 |
BTBD | BT Brands Inc | 2.17 | 0.28 | 14.81% | 289,534 |
CRNT | Ceragon Networks Ltd | 2.51 | 0.32 | 14.61% | 16 |
HTCO | High Trend International Group | 12.26 | 1.44 | 13.31% | 89 |
LOS ANGELES, April 6, 2026 /PRNewswire/ -- The DJS Law Group reminds investors of a class action lawsuit against Soleno Therapeutics, Inc. ("Soleno" or "the Company") (NASDAQ: SLNO) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
HANGZHOU, China, April 3, 2026 /PRNewswire/ -- Ridgetech, Inc., a Cayman Islands exempted company (the "Company") (Nasdaq: RDGT), a wholesale distributor of pharmaceutical and other healthcare products in China, today announced that it expects to implement a 1-for-150 reverse share split on its ordinary shares ("Ordinary Shares") effective Tuesday, April 7, 2026 at 5:00 p.m. Eastern Time, with trading to begin on a split‑adjusted basis at the market open on the next trading day. Trading in the Ordinary Shares will continue on the Nasdaq Capital Market under the symbol "RDGT." The new CUSIP number for the Ordinary Shares following the reverse share ...
Notifications have no immediate effect on the listing or trading of the Company's securities on NasdaqNasdaq has provided the Company until September 29, 2026 to regain compliance with both requirementsThe Company is actively evaluating actions to regain compliance, with a clear focus on initiatives that are aligned with and supportive of long-term shareholder valueCAMBRIDGE, Mass., April 3, 2026 /PRNewswire/ -- NeuroSense Therapeutics Ltd. (Nasdaq: NRSN) ("NeuroSense" or the "Company"), a late-stage clinical biotechnology company developing treatments for severe neurodegenerative diseases, today announced that it received two notification letters from the Listing Qualifications Department of The Nasdaq Stock Market LLC ("Nasdaq") on April ...
XCharge North America ("XCharge NA"), the North American subsidiary of XCHG Limited (Nasdaq: XCH) and a provider of high-power EV charging and battery-integrated solutions designed to strengthen the North American electrical grid, and JOJO Superfast EV Charging today announced a strategic partnership to deploy a high-power electric vehicle charging network across Illinois. Beyond manufacturing the chargers, XCharge NA will oversee every site from concept to completion through its comprehensive turnkey solutions team.
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions